NASDAQ:INDP | Profit Breakdown | Indaptus Therapeutics, Inc.

Complete filed revenue-to-profit bridge showing gross profit, operating income, pre-tax income and net income.

Available history
2020-03-31 to 2026-06-30
Data captured

Historical Profit Breakdown

DateRevenueGross profitOperating incomePre-tax incomeNet income
2026-06-30-$1.81M-$1.79M
2026-03-31-$2.16M-$2.54M
2025-12-31-$8.16M-$8.11M
2025-09-30-$2.65M-$2.98M
2025-06-30-$4.46M-$5.23M
2025-03-31-$4.57M-$4.53M
2024-12-31-$4.17M-$4.13M
2024-09-30-$3.14M-$3.07M
2024-06-30-$4.11M-$4.02M
2024-03-31-$3.94M-$3.81M
2023-12-31-$4.18M-$4M
2023-09-30-$4.25M-$3.92M
2023-06-30-$3.5M-$3.25M
2023-03-31-$4.46M-$4.25M
2022-12-31-$4.09M-$3.66M
2022-09-30-$3.55M-$3.47M
2022-06-30-$3.87M-$3.84M
2022-03-31-$3.4M-$3.37M
2021-12-31-$3.22M-$3.22M
2021-09-30-$3.37M-$3.37M
2021-06-30-$528,645.00-$7.42M-$515,479.00
2021-03-31-$613,975.00-$612,421.00
2020-12-31-$768,552.00-$770,219.00
2020-09-30-$1.55M-$1.54M
2020-06-30-$2.91M-$2.9M-$712,618.00
2020-03-31-$558,581.00

Annual Profit Breakdown

DateRevenueGross profitOperating incomePre-tax incomeNet income
2025-12-31-$19.83M-$20.85M-$20.85M
2024-12-31-$15.37M-$15.02M-$15.02M
2023-12-31-$16.38M-$15.42M
2022-12-31-$14.91M-$14.32M
2021-12-31-$7.73M-$7.71M
2020-12-31-$3.6M-$3.58M